PCA pumps represent 78.0% within the product segment in 2026. The patient-controlled analgesia pumps market was valued at USD 484.40 million in 2025, is projected to reach USD 837.21 million by 2036 and is forecast to post a 5.1% CAGR between 2026 and 2036, creating an incremental opportunity of USD 328.10 million.